Letter to the editor: 1-year clinical outcomes of bivalirudin vs. unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention
European Heart Journal - Cardiovascular Pharmacotherapy · 2024
DOI: 10.1093/ehjcvp/pvae010 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Heart Journal - Cardiovascular Pharmacotherapy, 2024. Verfasst von Fatima Rajab und 2 weiteren Autor:innen. Beteiligte Einrichtung: King Edward Medical University, Neela gumbad, Anarkali, Lahore, Pakistan. Hauptthemen laut MEDLINE: Hirudins, Percutaneous Coronary Intervention, Diabetes Mellitus, Type 2, Heparin. Die Arbeit nennt 8 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- King Edward Medical University, Neela gumbad, Anarkali, Lahore, Pakistan.
ORCID-Profile: Fatima Rajab, Aleena Mujahid, Bisal Naseer
Zitieren
APA
Rajab, F., Mujahid, A., & Naseer, B. (2024). Letter to the editor: 1-year clinical outcomes of bivalirudin vs. unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention. European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvae010
Vancouver
Rajab F, Mujahid A, Naseer B. Letter to the editor: 1-year clinical outcomes of bivalirudin vs. unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention. European Heart Journal - Cardiovascular Pharmacotherapy. 2024. doi:10.1093/ehjcvp/pvae010
BibTeX
@article{Rajab2024,
author = {Rajab, Fatima and Mujahid, Aleena and Naseer, Bisal},
title = {Letter to the editor: 1-year clinical outcomes of bivalirudin vs. unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention},
journal = {European Heart Journal - Cardiovascular Pharmacotherapy},
year = {2024},
doi = {10.1093/ehjcvp/pvae010}
}
EUVIMED